Cabergoline is a selective D2DR (D2-like receptor) agonist, similarly displaying a high affinity for several serotonin receptor subtypes. Cabergoline exhibits an inhibitory effect of the secretion of prolactin and growth hormone and has been shown to reverse levodopa-induced dyskinesias in Parkinsonian monkeys. Cabergoline is an activator of D3DR.
Eguchi et al (1995) Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors:in vitro culture studies. Endocr.J. 42 413. Hadj Tahar et al (2000) Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys. Cin.Neuropharmacol. 23 195. Kvernmo et al (2006) A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clin.Ther. 28 1065.
Soluble in water (partly miscible), DMSO (100 mM ), ethanol (100 mM), chloroform, and methanol.
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn
Create a new account
Email address already exists, please enter a new valid email address.Hide
USE YOUR SOCIAL NETWORK
Create an account quickly and easily with your preferred social network account. You won't have to remember an extra name and password.
Creating an account with us makes your shopping experience much easier and faster. You can save favorites, save cart, check order status and speed through checkout with saved addresses, payment methods and more.